BE870548A - Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic - Google Patents
Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnosticInfo
- Publication number
- BE870548A BE870548A BE190539A BE190539A BE870548A BE 870548 A BE870548 A BE 870548A BE 190539 A BE190539 A BE 190539A BE 190539 A BE190539 A BE 190539A BE 870548 A BE870548 A BE 870548A
- Authority
- BE
- Belgium
- Prior art keywords
- cosmetic
- pharmaceutical
- preparation
- new process
- diagnosis forms
- Prior art date
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0283—Matrix particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/652—The particulate/core comprising organic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mathematical Physics (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Drying Of Solid Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7728193A FR2403078A1 (fr) | 1977-09-19 | 1977-09-19 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
Publications (1)
Publication Number | Publication Date |
---|---|
BE870548A true BE870548A (fr) | 1979-03-19 |
Family
ID=9195532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE190539A BE870548A (fr) | 1977-09-19 | 1978-09-18 | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
Country Status (15)
Country | Link |
---|---|
US (1) | US4178695A (fr) |
JP (1) | JPS5495720A (fr) |
BE (1) | BE870548A (fr) |
CA (1) | CA1097209A (fr) |
CH (1) | CH633445A5 (fr) |
DE (1) | DE2840461A1 (fr) |
DK (1) | DK154528C (fr) |
ES (1) | ES473459A1 (fr) |
FR (1) | FR2403078A1 (fr) |
GB (1) | GB2004182B (fr) |
IE (1) | IE47020B1 (fr) |
IT (1) | IT1106901B (fr) |
LU (1) | LU80251A1 (fr) |
NL (1) | NL186675C (fr) |
SE (1) | SE444645B (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1209477A (fr) * | 1981-03-26 | 1986-08-12 | Bruce E. Haeger | Compose comprenant une preparation lyophilisee de derive de la penicilline |
US4429542A (en) * | 1981-08-10 | 1984-02-07 | Hoxan Corporation | Method of freezing fertilized ova, spermatozoa or the like and apparatus therefor |
JPS58154547A (ja) * | 1982-03-09 | 1983-09-14 | Nippon Shinyaku Co Ltd | アズレン誘導体の安定化法 |
ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
FR2539626B2 (fr) * | 1983-01-25 | 1985-06-21 | Lafon Labor | Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4712310A (en) * | 1986-09-15 | 1987-12-15 | E. I. Du Pont De Nemours And Company | Co-spray technique |
IL86892A (en) * | 1987-07-08 | 1993-04-04 | Lafon Labor | Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy |
JP2865320B2 (ja) * | 1989-08-07 | 1999-03-08 | 株式会社資生堂 | 固型化粧料組成物 |
FR2670675B1 (fr) * | 1990-12-20 | 1993-04-16 | Lafon Labor | Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels. |
IL101007A (en) * | 1992-02-18 | 1997-08-14 | Pharmos Ltd | Dry stable compositions prepared by lyophilization |
FR2702968B1 (fr) * | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
DE4342091A1 (de) * | 1993-12-09 | 1995-06-14 | Asta Medica Ag | Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
TW200744638A (en) * | 2001-01-26 | 2007-12-16 | Schering Corp | Combinations of bile acid sequestrant(s) and sterol absorption inhibitors and treatments for vascular indications |
US7071181B2 (en) * | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
HUP0303915A3 (en) * | 2001-01-26 | 2012-12-28 | Merck Sharp & Dohme | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
CA2434488A1 (fr) * | 2001-01-26 | 2002-08-01 | Harry R. Davis | Combinaisons d'acide nicotinique et de derives de ce dernier, inhibiteur(s) d'absorption de sterols et traitements de conditions vasculaires |
KR100820983B1 (ko) * | 2001-01-26 | 2008-04-10 | 쉐링 코포레이션 | 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물 |
JP2004517919A (ja) * | 2001-01-26 | 2004-06-17 | シェーリング コーポレイション | 血管状態の処置のための心臓血管薬剤とステロール吸収インヒビターとの組み合わせ |
AR032403A1 (es) * | 2001-01-26 | 2003-11-05 | Schering Corp | Combinaciones de inhibidor(es) de la absorcion de esterol con modificador(es) sanguineos para tratar cuadros vasculares |
US20030013699A1 (en) * | 2001-05-25 | 2003-01-16 | Davis Harry R. | Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
DK1429756T3 (da) * | 2001-09-21 | 2007-03-19 | Schering Corp | Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
EP1427409B1 (fr) * | 2001-09-21 | 2008-10-15 | Schering Corporation | Methodes de traitement ou de prevention d'une inflammation vasculaire au moyen d'un ou d'inhibiteurs d'absorption de sterol |
US6908626B2 (en) * | 2001-10-12 | 2005-06-21 | Elan Pharma International Ltd. | Compositions having a combination of immediate release and controlled release characteristics |
EP1487419A2 (fr) * | 2002-03-20 | 2004-12-22 | Elan Pharma International Limited | Formes posologiques a dissolution rapide presentant une friabilite reduite |
CA2504878A1 (fr) * | 2002-11-06 | 2004-05-27 | Schering Corporation | Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination |
CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
ATE406364T1 (de) | 2003-03-07 | 2008-09-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7192944B2 (en) * | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CA2523035C (fr) * | 2003-05-22 | 2011-04-26 | Elan Pharma International Ltd. | Sterilisation de dispersions d'agents actifs particulaires au moyen de rayons gamma |
WO2005046797A2 (fr) * | 2003-11-05 | 2005-05-26 | Schering Corporation | Combinaisons de modulateurs lipidiques et d'azetidinones substituees et traitements d'affections vasculaires |
JP4990632B2 (ja) * | 2004-01-28 | 2012-08-01 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 多孔質材料およびその製造方法 |
US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
EP1870649A1 (fr) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation visant à obtenir une humidité résiduelle déterminée par énergie de désorption aux niveaux limités |
US20090238867A1 (en) * | 2007-12-13 | 2009-09-24 | Scott Jenkins | Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
FR2945950A1 (fr) | 2009-05-27 | 2010-12-03 | Elan Pharma Int Ltd | Compositions de nanoparticules anticancereuses et procedes pour les preparer |
KR20220166856A (ko) | 2020-04-16 | 2022-12-19 | 타반타 테라퓨틱스 헝가리 인코포레이티드 | 전립선암을 치료하기 위한 방법 및 조성물 |
CN114532542A (zh) * | 2022-02-24 | 2022-05-27 | 山东坦途农业科技有限公司 | 一种夹心冻干赋型制剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2984992A (en) * | 1954-07-28 | 1961-05-23 | Union Carbide Corp | Apparatus for freeze dehydration of liquid bearing solids |
US3309779A (en) * | 1966-02-02 | 1967-03-21 | Fmc Corp | Dehydration of solids-bearing liquids |
GB1190319A (en) * | 1968-08-15 | 1970-05-06 | George Jarvis Tooby | Method for Dehydrating Materials |
DE1900995A1 (de) * | 1969-01-09 | 1970-08-27 | Struthers Scient And Internat | Gefriertrocknungsverfahren fuer Nahrungsmittel und dabei erhaltene Produkte |
FR2036890B1 (fr) * | 1969-04-15 | 1973-01-12 | Orsymonde | |
NL6915749A (en) * | 1969-10-17 | 1971-04-20 | Powdered products from fruit and vegetable juices aqs - vegetable extracts such as coffee, tea, etc having porous | |
FR2068447A1 (en) * | 1969-11-26 | 1971-08-27 | Orsymonde | Dehydrated pharmaceutical comps by - lyophilisation |
US3673698A (en) * | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
JPS503381A (fr) * | 1973-05-11 | 1975-01-14 | ||
JPS506532A (fr) * | 1973-05-22 | 1975-01-23 |
-
1977
- 1977-09-19 FR FR7728193A patent/FR2403078A1/fr active Granted
-
1978
- 1978-02-06 US US05/875,542 patent/US4178695A/en not_active Expired - Lifetime
- 1978-07-04 IE IE1341/78A patent/IE47020B1/en not_active IP Right Cessation
- 1978-07-20 SE SE7808007A patent/SE444645B/sv not_active IP Right Cessation
- 1978-07-26 DK DK333678A patent/DK154528C/da not_active IP Right Cessation
- 1978-08-07 GB GB7832497A patent/GB2004182B/en not_active Expired
- 1978-09-05 JP JP10903678A patent/JPS5495720A/ja active Granted
- 1978-09-15 CA CA311,409A patent/CA1097209A/fr not_active Expired
- 1978-09-15 IT IT51099/78A patent/IT1106901B/it active
- 1978-09-16 DE DE19782840461 patent/DE2840461A1/de active Granted
- 1978-09-18 LU LU80251A patent/LU80251A1/fr unknown
- 1978-09-18 BE BE190539A patent/BE870548A/fr not_active IP Right Cessation
- 1978-09-18 CH CH973478A patent/CH633445A5/fr not_active IP Right Cessation
- 1978-09-18 ES ES473459A patent/ES473459A1/es not_active Expired
- 1978-09-19 NL NLAANVRAGE7809522,A patent/NL186675C/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1106901B (it) | 1985-11-18 |
NL7809522A (nl) | 1979-03-21 |
DK154528B (da) | 1988-11-21 |
CA1097209A (fr) | 1981-03-10 |
GB2004182A (en) | 1979-03-28 |
SE7808007L (sv) | 1979-03-20 |
IE781341L (en) | 1979-03-19 |
DK154528C (da) | 1989-04-10 |
CH633445A5 (fr) | 1982-12-15 |
NL186675B (nl) | 1990-09-03 |
JPS62884B2 (fr) | 1987-01-10 |
ES473459A1 (es) | 1979-10-16 |
FR2403078B1 (fr) | 1981-07-03 |
SE444645B (sv) | 1986-04-28 |
DK333678A (da) | 1979-03-20 |
DE2840461A1 (de) | 1979-03-29 |
IE47020B1 (en) | 1983-11-30 |
LU80251A1 (fr) | 1979-03-07 |
FR2403078A1 (fr) | 1979-04-13 |
US4178695A (en) | 1979-12-18 |
DE2840461C2 (fr) | 1988-10-06 |
NL186675C (nl) | 1991-02-01 |
IT7851099A0 (it) | 1978-09-15 |
JPS5495720A (en) | 1979-07-28 |
GB2004182B (en) | 1982-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE870548A (fr) | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic | |
NL188078C (nl) | Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen. | |
MC1336A1 (fr) | Procede pour la preparation de compositions pharmaceutiques | |
NL7810138A (nl) | Werkwijze voor de bereiding van roomkaas. | |
IT1160900B (it) | Procedimento per la preparazione di dispersioni dei composti di cerio | |
NL7803166A (nl) | Nieuwe oximverbindingen van 3-acetoxymethyl- -7-amino-thiazolylaceetamidocefalosporaanzuur, werkwijze voor hun bereiding en onder toepassing daarvan verkregen geneesmiddelen. | |
NL7701849A (nl) | Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden. | |
NL187207C (nl) | Werkwijze voor de bereiding van pyrrolidineverbindingen. | |
NL7708009A (nl) | Werkwijze voor de bereiding van fosfaatzouten. | |
NL190119C (nl) | Werkwijze voor de bereiding van 4-hydroxy-5-alkyl- en 4-hydroxy-2,5-dialkyl-3-oxo-2h-furanen. | |
NL7803325A (nl) | Werkwijze voor de bereiding van 1-azolyl-3.3- -dimethyl-1-fenoxybutan-2-on-verbindingen. | |
NL187907C (nl) | Werkwijze voor de bereiding van fenylglyoxylzuuresters. | |
NL7803493A (nl) | Werkwijze voor de bereiding van thermostabiele weefselvormige melkalbuminen. | |
NL7807890A (nl) | Pyranochromoonderivaten, alsmede preparaten voor de be- handeling van allergische aandoeningen, die deze ver- bindingen bevatten. | |
NL7800001A (nl) | Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten. | |
NL7801158A (nl) | Werkwijze voor de bereiding van cyclohexaan- derivaten. | |
BE866662A (fr) | Procede de preparation de 3,5-dihalogenanilines | |
NL7605189A (nl) | Werkwijze ter bereiding van geneesmiddelen die 3,5-bisgeoxygeneerde 2-(omega-halogeen-3-geoxy- geneerde-1-alkenyl)-cyclopentaan-1-heptaanzuren en derivaten daarvan bevatten, alsmede de vol- gens deze werkwijze verkregen gevormde preparaten. | |
NL7812567A (nl) | Werkwijze voor de bereiding van menselijke chorionso- matomammotropine. | |
LU78854A1 (fr) | Procede de preparation d'une composition antimicrobienne de nettoyage de la peau | |
NL7803559A (nl) | Thiobenzylpyrimidine, werkwijze voor de bereiding hier- van en de toepassing van deze stof als geneesmiddel. | |
PT67885A (fr) | Procede de preparation de nouvelles compositions pharmaceutiques destinees notammentau traitement des troubles fonctionnels cerebraux. | |
BE871068A (fr) | Nouveau procede de preparation de 4-chloroquinoleines | |
FR2329283A1 (fr) | Preparation et formes unitaires pharmaceutiques et leur procede de preparation | |
NL7713862A (nl) | Werkwijze ter bereiding van op de 2-plaats ge- disubstitueerde fenyl-3.4-dihydro-4-oxochinazo- linederivaten, alsmede farmaceutische preparaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: LABORATOIRE L. LAFON Effective date: 19980918 |